WallStSmart

Intuitive Surgical Inc (ISRG)vsMeihua International Medical Technologies Co Ltd (MHUA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 12222% more annual revenue ($11.03B vs $89.55M). ISRG leads profitability with a 28.4% profit margin vs 10.3%. MHUA trades at a lower P/E of 0.3x. ISRG earns a higher WallStSmart Score of 66/100 (B-).

ISRG

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.0Quality: 7.8
Piotroski: 4/9Altman Z: 5.95

MHUA

Avoid

34

out of 100

Grade: F

Growth: 2.0Profit: 6.0Value: 6.7Quality: 8.5
Piotroski: 2/9Altman Z: 5.83
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ISRGUndervalued (+80.5%)

Margin of Safety

+80.5%

Fair Value

$1922.89

Current Price

$368.26

$1554.63 discount

UndervaluedFair: $1922.89Overvalued

Intrinsic value data unavailable for MHUA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.6%10/10

Strong operational efficiency at 33.6%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$131.94B9/10

Large-cap with strong market position

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
18.5%8/10

18.5% revenue growth

EPS GrowthGrowth
26.5%8/10

Earnings expanding 26.5% YoY

MHUA4 strengths · Avg: 10.0/10
P/E RatioValuation
0.3x10/10

Attractively priced relative to earnings

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.8310/10

Safe zone — low bankruptcy risk

Areas to Watch

ISRG2 concerns · Avg: 4.0/10
PEG RatioValuation
1.734/10

Expensive relative to growth rate

P/E RatioValuation
39.7x4/10

Premium valuation, high expectations priced in

MHUA4 concerns · Avg: 2.5/10
Market CapQuality
$425.43M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-16.2%2/10

Revenue declined 16.2%

EPS GrowthGrowth
-42.0%2/10

Earnings declined 42.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.6%. Revenue growth of 18.5% demonstrates continued momentum.

Bull Case : MHUA

The strongest argument for MHUA centers on P/E Ratio, Price/Book, Debt/Equity.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, P/E Ratio.

Bear Case : MHUA

The primary concerns for MHUA are Market Cap, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

ISRG profiles as a growth stock while MHUA is a declining play — different risk/reward profiles.

ISRG carries more volatility with a beta of 1.46 — expect wider price swings.

ISRG is growing revenue faster at 18.5% — sustainability is the question.

ISRG generates stronger free cash flow (948M), providing more financial flexibility.

Bottom Line

ISRG scores higher overall (66/100 vs 34/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

Meihua International Medical Technologies Co Ltd

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Meihua International Medical Technologies Co., Ltd. is engaged in the manufacturing and marketing of medical consumables in the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?